Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Therapy areas
Psychiatry
Psychiatry
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psychiatry
Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans
Biospace News
-
December 19, 2019
Psychiatry
Minerva Neurosciences scraps antidepressant drug candidate MIN-117 after failed mid-stage trial
Psychiatry
Axsome’s experimental drug AXS-05 hits main goal of late-stage major depressive disorder study
Psychiatry
Acadia details positive results from late-stage study of pimavanserin for dementia-related psychosis
Psychiatry
ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia
Psychiatry
Research Roundup: New Test for Autism and More
Biospace News
-
July 12, 2019
0
Psychiatry
Alkermes to Present New Data From Mental Health Portfolio at the...
Biospace News
-
May 22, 2019
0
Psychiatry
Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the...
Firstwordpharma News
-
May 16, 2019
0
Psychiatry
Once-Daily Trazodone as Effective as Venlafaxine XR for Major Depressive Disorder:...
Firstwordpharma News
-
April 10, 2019
0
Psychiatry
Achieve Life Sciences Announces Successful Completion of the Second and Final...
Biospace News
-
April 2, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
Checkmate Pharmaceuticals Announces Additions to Management Team
October 15, 2019
Peroxfarma Brings Epaplus Nutritional Supplements to American Consumers
February 5, 2019
Apellis Presents First Data on APL-2 in C3 Glomerulopathy at ASN...
November 8, 2019
Novartis announces NEJM publication of three pivotal trials showing durable and...
March 18, 2020
Load more
HOT NEWS
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
CEOCFO magazine interview with Machavert Pharmaceuticals CEO, Dr. Jakub Staszak-Jirkovsky
Phase III
GenSight Biologics Announces Presentation of 72-Week Data from the REVERSE &...
Phase I
EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase...
